Semaglutide
Semaglutide (Ozempic, Wegovy, Rybelsus)
Strongfat_lossmetabolic
Community score3.50 reviews · 0 tracking
An FDA-approved GLP-1 receptor agonist used for type 2 diabetes (Ozempic) and chronic weight management (Wegovy), with an oral form (Rybelsus). Large randomized trials show 12–17% body-weight reduction at the 2.4 mg weekly dose. One of the strongest evidence bases of any peptide listed here.
For research and personal log purposes. peptidio does not sell, ship, prescribe, or endorse any peptide for the prevention, treatment, or cure of any condition.